Pet anxiety is far from a top priority
Regarding “Lilly drug targets anxiety in dogs,” Consumer Briefs, April 22:
The Times reports that a major pharmaceutical company is making medicine to treat pet anxieties. As a person who has owned and loved pets, I can understand drugs that relieve pets’ pain and improve their medical condition.
As a counselor, I also know the value of medicines in treating psychological disorders, albeit a luxury of the developed world. But for pet anxiety?
It is shameful that we make and buy meds to keep Fido mentally stable, while millions of people with treatable or preventable conditions are dying.
Shame on the pharmaceutical companies for putting development dollars into pets instead of humanity.
RENEE BOWLING
Pasadena
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
